Janux Therapeutics, Inc. (JANX) Operating Lease, Right-of-Use Asset USD 2020 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Janux Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2020 to 2024.
Janux Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $20.5M, a 6.69% decline year-over-year.

Operating Lease, Right-of-Use Asset, Quarterly Data (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2024	$20.5M	-$1.47M	-6.69%	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$20.8M	-$1.44M	-6.47%	Dec 31, 2023	10-Q	2024-05-08
Q3 2023	$21.2M	-$1.46M	-6.42%	Sep 30, 2023	10-Q	2023-11-07
Q2 2023	$21.6M	-$1.19M	-5.22%	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$21.9M	+$21.8M	+16767%	Mar 31, 2023	10-Q	2023-05-09
Q4 2022	$22.3M	+$22.1M	+11943%	Dec 31, 2022	10-K	2024-03-08
Q3 2022	$22.7M	+$22.4M	+9422%	Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$22.8M			Jun 30, 2022	10-Q	2022-08-09
Q1 2022	$130K			Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$185K	+$185K		Dec 31, 2021	10-K	2023-03-10
Q3 2021	$238K			Sep 30, 2021	10-Q	2021-11-09
Q4 2020	$0			Dec 31, 2020	10-K	2022-03-18

* An asterisk sign (*) next to the value indicates that the value is likely invalid.